AllPennyStocks.com TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

TYRA Stock Heads For Best Day In Nearly 10 Months — Sets Date For Key Phase 2 Bladder Cancer Drug Readout

Tyra is set to host a conference call on September 9 to discuss initial results from its Phase 2 study evaluating Dabogratinib in patients with intermediate-risk non-muscle invasive bladder cancer.

Other Penny Stock Movers

Digestive Health Expansion Sends This Microcap Soaring
Enterprise Trial Converts Into Commercial AI Deal
AI Data Centers Are Being Rewired. One Critical Metal Is Moving With Them
Most Popular
{{ index + 1 }}


Back to Top